IL12A
Interleukin-12 subunit alpha
Also known as: CLMF, IL-12A, IL12A_HUMAN, NFSK, NKSF1, p35
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P29459
- Gene
- IL12A
- Ensembl
- ENSG00000168811
- Chromosome
- 3
- Canonical length
- 219 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
This gene encodes a subunit of a cytokine that acts on T and natural killer cells, and has a broad array of biological activities. The cytokine is a disulfide-linked heterodimer composed of the 35-kD subunit encoded by this gene, and a 40-kD subunit that is a member of the cytokine receptor family. This cytokine is required for the T-cell-independent induction of interferon (IFN)-gamma, and is important for the differentiation of both Th1 and Th2 cells. The responses of lymphocytes to this cytokine are mediated by the activator of transcription protein STAT4. Nitric oxide synthase 2A (NOS2A/NOS2) is found to be required for the signaling process of this cytokine in innate immunity. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
219 residues, UniProt reviewed canonical sequence.
>P29459|IL12A
1 MCPARSLLLV ATLVLLDHLS LARNLPVATP DPGMFPCLHH SQNLLRAVSN MLQKARQTLE
61 FYPCTSEEID HEDITKDKTS TVEACLPLEL TKNESCLNSR ETSFITNGSC LASRKTSFMM
121 ALCLSSIYED LKMYQVEFKT MNAKLLMDPK RQIFLDQNML AVIDELMQAL NFNSETVPQK
181 SSLEEPDFYK TKIKLCILLH AFRIRAVTID RVMSYLNASLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL12A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 4.1 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 4.1 nTPM
- fallopian tube: 2 nTPM
- lung: 2 nTPM
- midbrain: 1.7 nTPM
- amygdala: 1.5 nTPM
- basal ganglia: 1.5 nTPM
Single-cell type
- esophageal apical cells: 65 nCPM
- fallopian tube ciliated cells: 12 nCPM
- tuft cells: 12 nCPM
- endometrial ciliated cells: 5 nCPM
- hematopoietic stem cells: 4.4 nCPM
- respiratory ciliated cells: 4.2 nCPM
Immune cell
- naive B-cell: 2.2 nTPM
- memory CD8 T-cell: 0.6 nTPM
- T-reg: 0.6 nTPM
- eosinophil: 0.5 nTPM
- MAIT T-cell: 0.5 nTPM
- memory B-cell: 0.5 nTPM
Brain region
- cerebral cortex: 1.9 nTPM
- midbrain: 1.6 nTPM
- white matter: 1.6 nTPM
- pons: 1.4 nTPM
- amygdala: 1.3 nTPM
- thalamus: 1.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.82
- gnomAD pLI
- 0.05
- gnomAD missense Z
- 0.83
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell migration
- cellular response to virus
- defense response to Gram-positive bacterium
- extrinsic apoptotic signaling pathway
- immune response
- interleukin-12-mediated signaling pathway
- negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis
- negative regulation of interleukin-17 production
- negative regulation of protein secretion
- negative regulation of smooth muscle cell proliferation
- negative regulation of vascular endothelial growth factor signaling pathway
- positive regulation of cell adhesion
- positive regulation of dendritic cell chemotaxis
- positive regulation of lymphocyte proliferation
- positive regulation of mononuclear cell proliferation
- positive regulation of natural killer cell activation
- positive regulation of natural killer cell mediated cytotoxicity
- positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target
- positive regulation of NK T cell activation
- positive regulation of smooth muscle cell apoptotic process
- positive regulation of T cell mediated cytotoxicity
- positive regulation of type II interferon production
- positive regulation of tyrosine phosphorylation of STAT protein
- response to lipopolysaccharide
- response to UV-B
- response to virus
Molecular functions
- cytokine activity
- growth factor activity
- interleukin-12 receptor binding
- protein heterodimerization activity
- interleukin-12 beta subunit binding
- interleukin-27 binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Four-helical cytokine-like, core
- Interleukin-12
- Interleukin-12 alpha
- Interleukin-12 alpha subunit
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IL12A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL12A as an antibody target. Whether an autoantibody or antibody against IL12A could matter depends on whether native IL12A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL12A is annotated as secreted, so native IL12A circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label IL12A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...